Latin America & the Caribbean
For years, Gilead has worked with local partners to provide our medicines throughout Latin America and the Caribbean. Our efforts focus on addressing unmet medical needs in the region, bringing innovative treatments to communities in Argentina, Belize, Brazil, Haiti, Jamaica and beyond.
Following our mission to create a healthier world for all people, we identify and support organizations that seek to:
- Improve access to healthcare
- Reduce disparities for disadvantaged groups
- Advance education among patients and healthcare professionals
- Support local communities
In Latin America and the Caribbean, funding priority is given to projects that address HIV and liver diseases.
Eligible Countries
- Anguilla
- Antigua and Barbuda
- Argentina
- Aruba
- The Bahamas
- Barbados
- Belize
- Bolivia
- Brazil
- British Virgin Islands
- Cayman Islands
- Chile
- Colombia
- Costa Rica
- Cuba
- Curacao
- Dominica
- Dominican Republic
- Ecuador
- El Salvador
- Grenada
- Guatemala
- Guyana
- Haiti
- Honduras
- Jamaica
- Mexico
- Montserrat
- Nicaragua
- Panama
- Paraguay
- Peru
- Saint Maarten
- St. Kitts and Nevis
- St. Lucia
- St. Vincent & The Grenadines
- Suriname
- Trinidad and Tobago
- Turks and Caicos Islands
- Uruguay
- Venezuela
Funding Priorities
We’re committed to ending the HIV epidemic in Latin America and the Caribbean.
Numerous factors are driving the epidemic in this region. The social stigma of HIV-positive status leads many to decline treatment or travel great distances to be treated outside their community. Elsewhere, poor treatment options for incarcerated populations (a group that faces systemic barriers to receiving quality HIV care) leads to public health concerns as individuals complete their rehabilitation programs and re-enter society.
We support organizations working to help individuals learn their HIV status and get the care they need. We also fund local groups looking to meet the unique needs of the region, including:
- Increasing awareness and understanding of HIV incidence and treatment methods
- Facilitating medicine provision and local provider expertise
- Supporting linkage to care programs
- Identifying and fostering prevention programs for at-risk individuals, including via pre-exposure prophylaxis (PrEP)
In Latin America and the Caribbean, many people are living with undiagnosed hepatitis C, driven in part by a lack of disease awareness and diagnosis options have contributed to the persistence of this gap.
Our grantee partners seek to increase awareness of risk factors and the educational tools available to patient communities throughout the region. We also fund projects to improve diagnostics and build medical specialization in hepatitis B (HBV) and HCV.
We are working to improve the overall continuum of care for liver diseases by funding organizations that:
- Ensure providers have the training and expertise they need to deliver proper care
- Improve infrastructure and screening ability of regions where care is dependent on viral load
- Reduce undiagnosed totals
- Increase awareness of risk factors
Though priority is given to projects that address HIV and liver disease, we consider grant proposals outside of these therapeutic areas, provided they conform to our eligibility restrictions. These proposals may include (but are not limited to):
- Access and education surrounding antifungal treatments
- Social services (homeless shelters, food banks, etc.)
- Community vibrancy projects (STEM education, arts support, community beautification, etc.)
Before applying, carefully review Apply for Funding, Terms and Conditions and FAQs. If you are looking for other types of funding, see also Medical Education and Research Funding Programs.
All grant applications must include a U.S. federal tax ID number. If you are a nonprofit organization, please also include your proof of status (e.g., a 501(c)(3) IRS letter). Only organizations, not individuals, are eligible to apply.
You will submit your grant application via our secure online system.
Be prepared to submit the following information to the online application:
- Dates and locations of project events (please note that grant funding is not provided for more than one year at a time)
- Final event agenda (please do not include the names or affiliations of presenting speakers)
- Target audience and publicity plan
- Detailed project budget, including a breakdown of how you will use the funds requested from Gilead, as well as total estimated project expenses
- Number of medical education credits offered and accreditation information (where applicable)
Note: The portal offers the option to save an uncompleted draft and return to it at another time.
Please review your application carefully before submitting it, as changes cannot be made after submission. We will send you a confirmation email after receiving your application.
Apply for a Grant
We accept grant applications year-round. Keep in mind that you must submit the application at least six weeks before your activity begins, and that it typically takes approximately six to 12 weeks for review.
We will email the contact listed on your grant account profile with notification of the funding decision.
Access the Grant Portal Terms and Conditions FAQs